Acute Lymphoblastic Leukemia, Adult B-Cell Clinical Trials in Beijing, Beijing Municipality

Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).